[go: up one dir, main page]

AU2003287840A1 - Arylthioetherpyrimidine and aryloxyetherpyrimidine derivatives and their therapeutic uses - Google Patents

Arylthioetherpyrimidine and aryloxyetherpyrimidine derivatives and their therapeutic uses

Info

Publication number
AU2003287840A1
AU2003287840A1 AU2003287840A AU2003287840A AU2003287840A1 AU 2003287840 A1 AU2003287840 A1 AU 2003287840A1 AU 2003287840 A AU2003287840 A AU 2003287840A AU 2003287840 A AU2003287840 A AU 2003287840A AU 2003287840 A1 AU2003287840 A1 AU 2003287840A1
Authority
AU
Australia
Prior art keywords
arylthioetherpyrimidine
aryloxyetherpyrimidine
derivatives
therapeutic uses
therapeutic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003287840A
Inventor
Bruce P. Connop
David D. Macdonald
Parimal Nathwani
Michael G. Organ
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Active Pass Pharmaceuticals Inc
Original Assignee
Active Pass Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Active Pass Pharmaceuticals Inc filed Critical Active Pass Pharmaceuticals Inc
Publication of AU2003287840A1 publication Critical patent/AU2003287840A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/56—One oxygen atom and one sulfur atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/52—Two oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/60—Three or more oxygen or sulfur atoms

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2003287840A 2002-12-16 2003-12-16 Arylthioetherpyrimidine and aryloxyetherpyrimidine derivatives and their therapeutic uses Abandoned AU2003287840A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US43403002P 2002-12-16 2002-12-16
US60/434,030 2002-12-16
PCT/CA2003/001962 WO2004054988A1 (en) 2002-12-16 2003-12-16 Arylthioetherpyrimidine and aryloxyetherpyrimidine derivatives and their therapeutic uses

Publications (1)

Publication Number Publication Date
AU2003287840A1 true AU2003287840A1 (en) 2004-07-09

Family

ID=32595259

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003287840A Abandoned AU2003287840A1 (en) 2002-12-16 2003-12-16 Arylthioetherpyrimidine and aryloxyetherpyrimidine derivatives and their therapeutic uses

Country Status (2)

Country Link
AU (1) AU2003287840A1 (en)
WO (1) WO2004054988A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0608386D0 (en) * 2006-04-27 2006-06-07 Senexis Ltd Compounds

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030125338A1 (en) * 2001-06-12 2003-07-03 Active Pass Pharmaceuticals, Inc. Compounds, compositions and methods for modulating beta-amyloid production

Also Published As

Publication number Publication date
WO2004054988A1 (en) 2004-07-01

Similar Documents

Publication Publication Date Title
AU2003266321A1 (en) Tetrahydropyrimidine-2-one derivatives and their uses
AU2003235676A1 (en) Tricyclic-bis-enone derivatives and methods of use thereof
AU2003249909A1 (en) Phenoxypropenylphenyl derivatives and their use as herbicides
AU2003303388A1 (en) Triptolide derivatives and their use
AU2003255645A1 (en) Piperazinylacylpiperidine derivatives, their preparation and therapeutic use thereof
IL163868A0 (en) Hermiasterlin derivatives and uses thereof
AU2003281044A1 (en) Pyrrolopyridine derivative and use thereof
AU2003235956A1 (en) Quinazoline derivative and medicine
AU2003294318A1 (en) Therapeutic bioconjugates
AU2003269018A1 (en) Acylaminothiazole derivatives, preparation and therapeutic use thereof
AU2003296369A1 (en) Imminoamines and preparation thereof
AU2003249722A1 (en) Therapeutic amides
AU2003247005A1 (en) Therapy combination
AU2003245794A1 (en) Glycosaminoglycan-dnase combination therapy
AU2003297612A1 (en) 2-substituted-3-propenamide derivatives and methods of using the same
AU2003281691A1 (en) Furoisoquinoline derivative and use thereof
AU2003252684A1 (en) N-acetylglucosamine derivatives and use thereof
AU2003251513A1 (en) Rsk inhibitors and therapeutic uses thereof
AU2003231827A1 (en) Pseudo-tissues and uses thereof
AU2003900495A0 (en) Aroylhydrazone derivatives and therapeutic uses thereof
AU2003240052A1 (en) Il-11 derivatives and therapeutic uses thereof
AU2003302173A1 (en) Spirotetrathiocarbamates and spirooxothiocarbamates
AU2002308105A1 (en) Benzoaxathiepin derivatives and their use as medicines
AU2003264474A1 (en) Novel uracil derivatives and medicinal use thereof
AU2003287840A1 (en) Arylthioetherpyrimidine and aryloxyetherpyrimidine derivatives and their therapeutic uses

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase